SCHEMBL560210

SCHEMBL560210

C=CCNc1c2ccccc2nc2ccccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 6/20 0.58
KMT2A Q03164 6/20 0.58
RAD52 P43351 5/20 0.58
RAB9A P51151 4/20 0.56
KDM4E B2RXH2 4/20 0.56
ALDH1A1 P00352 3/20 0.56
GAA P10253 2/20 0.56
GLA P06280 2/20 0.56
MITF O75030 1/20 0.56
LMNA P02545 1/20 0.56
TTR P02766 1/20 0.56
MEN1 O00255 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
MAPT P10636 1/20 0.54
SLC2A1 P11166 4/20 0.53
NPC1 O15118 1/20 0.53
APOBEC3A P31941 1/20 0.53
APOBEC3G Q9HC16 1/20 0.53
TSHR P16473 1/20 0.51
NPY1R P25929 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5452943 0.81 KDM4E (0.48) POLBKMT2ARAD52RAB9AKDM4E
SCHEMBL1537966 0.79 BCHE (0.67) SLC2A1
SCHEMBL13692594 0.79 BCHE (0.67) KMT2AKDM4EMEN1SLC2A1
SCHEMBL8608662 0.79 POLB (0.63) POLBKMT2ARAD52RAB9AKDM4E
SCHEMBL4980653 0.78 KMT2A (0.59) POLBKMT2ARAD52RAB9AKDM4E
SCHEMBL2946229 0.78 CHRM2 (0.65) POLBKMT2ARAB9AKDM4EALDH1A1
SCHEMBL10899951 0.78 KDM4E (0.44) POLBKMT2ARAD52RAB9AKDM4E
SCHEMBL7880366 0.78 POLB (0.78) POLBKMT2ARAD52RAB9AKDM4E
SCHEMBL9287754 0.77 SUMO3 (0.72) KMT2ARAD52RAB9AKDM4EALDH1A1
SCHEMBL5463526 0.77 KMT2A (0.54) POLBKMT2ARAD52RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120035320-A1 POLYACRIDINE NUCLEIC ACID DELIVERY PEPTIDE COMPLEXES UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2012-02-09 US claimed
US-20140151548-A1 MATRIX FOR MALDI MASS SPECTROMETRY AND MALDIMASS SPECTROMETRY METHOD KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2014-06-05 US disclosed
US-20140151548-A1 MATRIX FOR MALDI MASS SPECTROMETRY AND MALDIMASS SPECTROMETRY METHOD KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2014-06-05 US disclosed
EP-2284611-B1 PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE ELEMENT, RESIST PATTERN MANUFACTURING METHOD, AND PRINTED CIRCUIT BOARD MANUFACTURING METHOD HITACHI CHEMICAL CO LTD (JP) 2013-11-20 EP disclosed
US-8460853-B2 Photosensitive resin composition, photosensitive element, resist pattern manufacturing method, and printed circuit board manufacturing method HITACHI CHEMICAL COMPANY, LTD. (JP) 2013-06-11 US disclosed
US-20120040290-A1 PHOTOSENSITIVE RESIN COMPOSITION, AND PHOTOSENSITIVE ELEMENT, RESIST PATTERN FORMATION METHOD AND PRINTED CIRCUIT BOARD PRODUCTION METHOD EACH UTILIZING SAME HITACHI CHEMICAL COMPANY, LTD. (JP) 2012-02-16 US disclosed
US-20120035320-A1 POLYACRIDINE NUCLEIC ACID DELIVERY PEPTIDE COMPLEXES UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2012-02-09 US disclosed
US-20110081616-A1 PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE ELEMENT, RESIST PATTERN MANUFACTURING METHOD, AND PRINTED CIRCUIT BOARD MANUFACTURING METHOD HITACHI CHEMICAL COMPANY, LTD. (JP) 2011-04-07 US disclosed
EP-2284611-A1 PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE ELEMENT, RESIST PATTERN MANUFACTURING METHOD, AND PRINTED CIRCUIT BOARD MANUFACTURING METHOD Hitachi Chemical Company, Ltd. (JP) 2011-02-16 EP disclosed
US-7232663-B2 Assays employing novel substrates for measuring P450-mediated N-dealkylation THE UNIVERSITY OF WYOMING (US) 2007-06-19 US disclosed
US-20070015235-A1 Assays employing novel substrates for measuring P450-mediated N-dealkylation UNIVERSITY OF WYOMING, THE 2007-01-18 US disclosed
US-4820714-A QUINACRINE OR DIMETHYL D,1-2,3-DISTEAROYLOXYPROPYL-2*-HYDROXYETHYL AMMONIUM ACETATE UNIVERSITY OF VIRGINIA ALUMNI PATENTS FOUNDATION (US) 1989-04-11 US disclosed
US-4590277-A BACTERICIDES, ANTITUMOR AGENTS DEVELOPMENT FINANCE CORPORATION OF NEW ZEALAND (NZ) 1986-05-20 US disclosed
US-4575553-A 4'-(9-ACRIDINYLAMINO)-METHANESULFON-M-==ANISIDE BRISTOL-MYERS COMPANY (US) 1986-03-11 US disclosed
EP-0165592-A2 Antitumor agents Bristol-Myers Company (US) 1985-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035320-A1 POLYACRIDINE NUCLEIC ACID DELIVERY PEPTIDE COMPLEXES NUP205, PABPC1, SARNP POLB 102/4885KMT2A 2891/4885RAD52 1538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.